[German Hypertension League update. What does the ALLHAT Study really mean?].
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000145:classification / Q000191:economics / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000145:classification / Q000191:economics / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000145:classification / Q000191:economics / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000191:economics / Q000401:mortality / Q000517:prevention & control; D002423:Cause of Death; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D004232:Diuretics / Q000145:classification / Q000191:economics / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005858:Germany; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000191:economics / Q000401:mortality; D014481:United States
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004232:Diuretics